In SCID mice receiving syngeneic thymocytes, rhGH significantly improved lymph-node T-cell engraftment.
In plain wordsIn mice with immune deficiency receiving thymocytes, rhGH improved T-cell engraftment in lymph nodes.
- Peptide
- HGH (somatotropin)
- Outcome
- IncreaseSyngeneic T-cell engraftment
- Study
mousen: not reported in source
SCID mice- Outcome group
- Immune response · Immune and inflammation
- Studied dose
- Dose not stated
Source sentences
SCID mice receiving syngeneic thymocytes and treated with recombinant human GH (rhGH) had significantly better T-cell engraftment in their lymph nodes.
1 context sentence(design, population, supporting numbers)
Growth hormone (GH) has previously been implicated in T-cell development, and here we test its efficacy in promoting T-lymphocyte engraftment in mice with severe combined immune deficiency (SCID).